Me about the efficacy of FMD - the fasting mimicking diet
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
I appreciate your question about fasting mimicking diet (FMD) and its potential role in cancer care. However, I need to be straightforward with you: I don't have specific clinical evidence in my current knowledge base about FMD efficacy for cancer patients, particularly in the context of your situation.
Here's what I can tell you:
What the Evidence Shows (and Doesn't)
The NCCN Guidelines for cancer patients focus on established, evidence-based supportive care strategies—things like managing side effects, nutrition counseling, and symptom management. FMD is an emerging area of research, but it's not yet part of standard NCCN recommendations for cancer treatment or survivorship.
Why this matters for you: Given that you've been experiencing shortness of breath (SOB) symptoms for about 3.5 months and are on Letrozole (which can have pulmonary side effects), any dietary changes—especially restrictive ones like fasting—should be discussed with your care team first. Fasting could potentially affect:
- Your energy levels during treatment
- Your ability to tolerate medications
- Nutritional status (important when managing treatment side effects)
Questions to Ask Your Oncology Team
Since FMD is outside standard guidelines, I'd recommend asking your doctor:
- "Is there any clinical evidence that FMD would be beneficial for my specific situation?"
- "Could fasting interact with my current medications (Letrozole) or affect my SOB symptoms?"
- "Would a registered dietitian be helpful to discuss nutrition strategies that are evidence-based?"
- "Are there any clinical trials involving FMD that I should know about?"
What IS Supported
According to NCCN Guidelines, what is recommended for cancer patients includes:
- Working with a registered oncology dietitian
- Maintaining adequate nutrition during treatment
- Managing treatment side effects through supportive care
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Would you like me to help you understand more about managing your current symptoms or preparing questions for your next appointment?
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...
TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2